Daré Bioscience (DARE) investor relations material

Opening remarks and agenda

• Meeting commenced at 9:00 A.M. Pacific Time with introductions of directors, executive officers, and the independent auditor representative.

• Chairperson outlined meeting procedures, including voting and Q&A protocols.

Shareholder proposals

• Eight proposals were presented, including director elections, auditor ratification, executive compensation, voting frequency, equity issuance, stock plan amendment, and potential adjournments.

Overview of voting outcomes

• Gregory Matz and Sabrina Martucci Johnson elected as Class III directors.

• Haskell & White LLP ratified as independent auditor for fiscal year 2026.

• Executive compensation approved on an advisory basis; annual frequency preferred for future votes.

• Approval granted for potential future share issuance to Lincoln Park and amendment to increase shares in the 2022 Stock Incentive Plan by 1,500,000.

• Adjournment proposals for additional proxy solicitation, if needed, were approved.